Astrotech's Cash & cash equivalent grew by 72.2 % in the Q4 2026 sequentially, faster than Current Liabilities, this led to improvement in Astrotech's Quick Ratio to 5.02, Quick Ratio remained below Astrotech Corp average.

Within Laboratory Analytical Instruments industry 4 other companies have achieved higher Quick Ratio than Astrotech in fourth quarter 2026. While Quick Ratio total ranking has improved so far during the Q4 2026 to 810, from total ranking in the third quarter 2026 at 859.

Explain Quick Ratio?
How much Cash & cash equivalents ASTC�s has?
What are ASTC�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ASTC Quick Ratio	(Jun 30 2026) Q4	(Mar 31 2026) Q3	(Dec 31 2025) Q2	(Sep 30 2025) Q1	(Jun 30 2025) Q4
Y / Y Current Liabilities Change	-7.92 %	-26.36 %	-3.05 %	-12.6 %	-3.05 %
Y / Y Cash & cash equivalent Change	-37.75 %	-68.46 %	-42.95 %	-50.77 %	-42.95 %
Quick Ratio MRQ	5.02	3.59	7.43	7.5	7.43
ASTC's Total Ranking	# 810	# 859	# 564	# 403	# 348
Seq. Current Liabilities Change	23 %	-25.13 %	31.85 %	-24.15 %	-1.65 %
Seq. Cash & cash equivalent Change	72.2 %	-63.85 %	30.65 %	-23.46 %	-12.75 %

Quick Ratio fourth quarter 2026 Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 5
Healthcare Sector	# 304
Overall Market	# 810

Quick Ratio Statistics
High	Average	Low
90.72	11.53	0.38
(Dec 31 2016)		(Dec 31 2014)

Financial Statements
Astrotech's Current Liabilities	$ 2 Millions	Visit ASTC's Balance sheet
Astrotech's Cash & cash equivalent	$ 11 Millions	Visit ASTC's Balance sheet
Source of ASTC's Sales		Visit ASTC's Sales by Geography

Cumulative Astrotech's Quick Ratio

ASTC's Quick Ratio for the trailling 12 Months

ASTC Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-12.46 %	-11.15 %	-3.89 %	-4.45 %	-2.91 %
Y / Y Cash & cash equivalent TTM Growth	-49.59 %	-49.62 %	-43.84 %	-38.02 %	-32.76 %
Quick Ratio TTM	5.96	6.62	7.7	9.1	10.35
Total Ranking TTM	# 3816	# 2827	# 2671	# 2195	# 2631
Seq. Current Liabilities TTM Growth	-2.26 %	-7.1 %	-0.83 %	-2.79 %	-0.8 %
Seq. Cash & cash equivalent TTM Growth	-12.07 %	-20.06 %	-16.14 %	-14.47 %	-12.13 %

Quick ratio ranking by company, industry and sector >> Back to ASTC Financial Strength Comparisons >> Go to Compare ASTC Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in ASTC's Current Liabilities to $2.26 millions, cumulative Quick Ratio to 5.96 above the company average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 21 other companies have achieved higher Quick Ratio than Astrotech. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2026 from 2827 to 3816.

Explain Quick Ratio?
How much Cash & cash equivalents ASTC�s has?
What are ASTC�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Laboratory Analytical Instruments Industry	# 22
Healthcare Sector	# 881
Within the Market	# 3816

trailing twelve months Quick Ratio Statistics
High	Average	Low
12.13	3.21	0.46
(Jun 30 2022)		(Jun 30 2018)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Laboratory Analytical Instruments Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Alamar Biosciences Inc	8.94	$ 250.052 Millions	$ 27.960 Millions
Eyepoint Inc	7.80	$ 327.214 Millions	$ 41.943 Millions
Astrotech Corp	5.02	$ 11.334 Millions	$ 2.257 Millions
Scientific Industries Inc	4.92	$ 7.882 Millions	$ 1.602 Millions
Standard Biotools Inc	4.75	$ 270.026 Millions	$ 56.802 Millions
10x Genomics Inc	4.66	$ 552.058 Millions	$ 118.509 Millions
Pacific Biosciences Of California Inc	3.44	$ 236.873 Millions	$ 68.806 Millions
Cytek Biosciences Inc	2.83	$ 262.004 Millions	$ 92.698 Millions
Quanterix Corporation	1.86	$ 93.529 Millions	$ 50.373 Millions
Nautilus Biotechnology Inc	1.52	$ 13.166 Millions	$ 8.639 Millions
Rapid Micro Biosystems Inc	1.13	$ 20.500 Millions	$ 18.150 Millions
Bionano Genomics Inc	1.04	$ 10.420 Millions	$ 10.039 Millions

Date modified: 2026-09-27T08:12:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.